A Study of MORAb-009 in Subjects With Pancreatic Cancer, Mesothelioma, or Certain Types of Ovarian or Lung Cancer
This study is currently recruiting patients.
Verified by Morphotek July 2006
Sponsored by:
Morphotek
Information provided by:
Morphotek
ClinicalTrials.gov Identifier:
NCT00325494
Purpose
The purpose of this study is to establish the safest doses of an investigational drug called MORAb-009 in subjects with pancreatic cancer, mesothelioma, or certain types […]